← Back to Patent Explorer
US4120730A Expired / Lapsed US ⏱️ 0.0 years remaining

Biocompatible ceramic glass

Assignee: Battelle Memorial Institute Inc
•
Filing: 1976-02-18
•
Granted: 1978-10-17
•
Expires: 1996-02-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A biocompatible glass ceramic consisting of a vitreous matrix containing vitreous inclusions in which are dispersed crystals of a compound, isomorphous with hydroxyapatite, of at least the following elements: calcium, a lanthanide or yttrium, silicon, phosphorus and oxygen, these inclusions being surrounded by crystals of at least one compound belonging to the group consisting of Na 2 Ca 2 Si 3 O 9 and Ca 3 (PO 4 ) 2 .2 Ca 2 SiO 4 , can be used to construct artificial bone segments etc in bone surgery and bonds firmly with the new bone tissue without causing inflammation.

Inventors

  • 👤 Felix Trojer
  • 👤 Grahame Paul O'Connor
  • 👤 Helmut Tannenberger

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:16
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/02; A61L27/10; A61L27/12; C; C03; C03C; C03C10/00; C03C10/0009; C03C4/00; C03C4/0007; A61F; A61F2310/00; A61F2310/00005; A61F2310/00179; A61F2310/00293; Y; Y10; Y10S; Y10S623/00; Y10S623/92; Y10S623/923

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 166 words
A biocompatible glass ceramic consisting essentially of a Na 2 O, CaO and SiO 2 vitreous matrix containing vitreous inclusions in which are dispersed crystals of a compound isomorphous with hydroxyapatite and having the formula Ca.sub.(10-x) M x Si x P.sub.(6-x) O 24 F 2 , where x is 2 to 6 and M is a lanthanide or yttrium, and crystals of Na 2 Ca 2 Si 3 O 9 and Ca 3 (PO 4 ) 2 .2Ca 2 SiO 4 in said matrix, said crystals being present in an effective amount to permit bonding of said glass ceramic to bone, the glass ceramic being prepared from a mixture having the following molar percentage limits: SiO 2 = 35 to 50 Na 2 O = 20 to 30 CaO = 10 to 30 P 2 o 5 = 2.5 to 10 lanthanide or yttrium oxide = 3 to 10 alumina = up to 5 sodium fluoride = up to 10 calcium fluoride = up to 5.
Claim 2
Dependent Claim 166 words
A biocompatible glass ceramic consisting essentially of a Na 2 O, CaO and SiO 2 vitreous matrix containing vitreous inclusions in which are dispersed crystals of a compound isomorphous with hydroxyapatite and having the formula Ca.sub.(10-x) M x Si x P.sub.(6-x) O 24 F 2 , where x is 2 to 6 and M is a lanthanide or yttrium, and crystals of Na 2 Ca 2 Si 3 O 9 and Ca 3 (PO 4 ) 2 .2Ca 2 SiO 4 in said matrix, said crystals being present in an effective amount to permit bonding of said glass ceramic to bone, the glass ceramic being prepared from a mixture having the following molar percentage limits: SiO 2 = 35 to 50 Na 2 O = 20 to 30 CaO = 10 to 30 P 2 o 5 = 2.5 to 10 lanthanide or yttrium oxide = 3 to 10 alumina = up to 5 sodium fluoride = up to 10 calcium fluoride = up to 5.
Claim 3
Dependent Claim 12 words
The glass ceramic defined in claim 1 wherein said lanthanide is lanthanum.
Claim 4
Dependent Claim 25 words
The glass ceramic defined in claim 2 wherein said compound isomorphous with hydroxyapatite is a compound of the formula Ca.sub.10-x La.sub.x Si.sub.x P.sub.6-x O.sub.25 .
Claim 5
Dependent Claim 26 words
The glass ceramic defined in claim 1 wherein said compound isomorphous with hydroxyapatite is a compound of the formula Ca.sub.6 La.sub.4 Si.sub.2 P.sub.4 O.sub.24 F.sub.2 .
Claim 6
Dependent Claim 80 words
The glass ceramic defined in claim 1 wherein said crystals isomorphous with hydroxyapatite include said lanthanide or yttrium in a nontoxic quantity but sufficient to permit partial dissolution of the glass ceramic to form holes and allow growth of bone tissue in these holes whereby the lanthanide or yttrium is incorporated in the bone tissue thus grown in the holes whereby epitaxy exists between the hydroxyapatite phase of the bone and crystals of the ceramic glass isomorphous with the hydroxyapatite.

References Cited (Backward Citations)

US3241935A Cited
US3929971A Cited
US3922155A Cited
US3919723A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-10-16 1982-04-17 1982-10-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-10-16 1986-04-17 1986-10-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-10-16 1990-04-17 1990-10-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag